{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:09:40Z","timestamp":1792008580638,"version":"4.4.0"},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The p53 protein is critical for multiple cellular functions including cell growth and DNA repair. We assessed whether polymorphisms in the region encoding TP53 were associated with risk of invasive ovarian cancer. The study population includes a total of 5,206 invasive ovarian cancer cases (2,829 of which were serous) and 8,790 controls from 13 case-control or nested case-control studies participating in the Ovarian Cancer Association Consortium (OCAC). Three of the studies performed independent discovery investigations involving genotyping of up to 23 single nucleotide polymorphisms (SNP) in the TP53 region. Significant findings from this discovery phase were followed up for replication in the other OCAC studies. Mixed effects logistic regression was used to generate posterior median per allele odds ratios (OR), 95% probability intervals (PI), and Bayes factors (BF) for genotype associations. Five SNPs showed significant associations with risk in one or more of the discovery investigations and were followed up by OCAC. Mixed effects analysis confirmed associations with serous invasive cancers for two correlated (r2 = 0.62) SNPs: rs2287498 (median per allele OR, 1.30; 95% PI, 1.07\u20131.57) and rs12951053 (median per allele OR, 1.19; 95% PI, 1.01\u20131.38). Analyses of other histologic subtypes suggested similar associations with endometrioid but not with mucinous or clear cell cancers. This large study provides statistical evidence for a small increase in risk of ovarian cancer associated with common variants in the TP53 region. [Cancer Res 2009;69(6):2349\u201357]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-2902","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T22:26:11Z","timestamp":1236723971000},"page":"2349-2357","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Single Nucleotide Polymorphisms in the\n                    <i>TP53<\/i>\n                    Region and Susceptibility to Invasive Epithelial Ovarian Cancer"],"prefix":"10.1158","volume":"69","author":[{"given":"Joellen M.","family":"Schildkraut","sequence":"first","affiliation":[{"name":"1Comprehensive Cancer Center, Departments of"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"2Community and Family Medicine,"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen L.","family":"Goode","sequence":"additional","affiliation":[{"name":"6Mayo Clinic College of Medicine, Rochester, Minnesota;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlise A.","family":"Clyde","sequence":"additional","affiliation":[{"name":"5Department of Statistical Science, Duke University, Durham, North Carolina;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin S.","family":"Iversen","sequence":"additional","affiliation":[{"name":"1Comprehensive Cancer Center, Departments of"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"5Department of Statistical Science, Duke University, Durham, North Carolina;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia G.","family":"Moorman","sequence":"additional","affiliation":[{"name":"1Comprehensive Cancer Center, Departments of"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"2Community and Family Medicine,"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[{"name":"1Comprehensive Cancer Center, Departments of"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"3Obstetrics and Gynecology, and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Marks","sequence":"additional","affiliation":[{"name":"1Comprehensive Cancer Center, Departments of"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"4Surgery, Duke University Medical Center, and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Lissowska","sequence":"additional","affiliation":[{"name":"7Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Warsaw, Poland;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Brinton","sequence":"additional","affiliation":[{"name":"8Division of Cancer Epidemiology and Genetics, National Cancer Institute and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Peplonska","sequence":"additional","affiliation":[{"name":"10Department of Occupational and Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"6Mayo Clinic College of Medicine, Rochester, Minnesota;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[{"name":"6Mayo Clinic College of Medicine, Rochester, Minnesota;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rider","sequence":"additional","affiliation":[{"name":"6Mayo Clinic College of Medicine, Rochester, Minnesota;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[{"name":"11The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia for Australian Cancer Study and the Australian Ovarian Cancer Group;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope M.","family":"Webb","sequence":"additional","affiliation":[{"name":"11The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia for Australian Cancer Study and the Australian Ovarian Cancer Group;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Beesley","sequence":"additional","affiliation":[{"name":"11The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia for Australian Cancer Study and the Australian Ovarian Cancer Group;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Chen","sequence":"additional","affiliation":[{"name":"11The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia for Australian Cancer Study and the Australian Ovarian Cancer Group;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Phelan","sequence":"additional","affiliation":[{"name":"13H. Lee Moffitt Cancer Center, Tampa, Florida;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sutphen","sequence":"additional","affiliation":[{"name":"13H. Lee Moffitt Cancer Center, Tampa, Florida;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Sellers","sequence":"additional","affiliation":[{"name":"13H. Lee Moffitt Cancer Center, Tampa, Florida;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Pearce","sequence":"additional","affiliation":[{"name":"14Department of Preventive Medicine, USC\/Keck School of Medicine, Norris Comprehensive Cancer Center,"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.","family":"Wu","sequence":"additional","affiliation":[{"name":"14Department of Preventive Medicine, USC\/Keck School of Medicine, Norris Comprehensive Cancer Center,"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Van Den Berg","sequence":"additional","affiliation":[{"name":"15Department of Urology, University of Southern California Norris Comprehensive Cancer Center, and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Conti","sequence":"additional","affiliation":[{"name":"14Department of Preventive Medicine, USC\/Keck School of Medicine, Norris Comprehensive Cancer Center,"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Elund","sequence":"additional","affiliation":[{"name":"16University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Anderson","sequence":"additional","affiliation":[{"name":"16University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Goodman","sequence":"additional","affiliation":[{"name":"17Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Lurie","sequence":"additional","affiliation":[{"name":"17Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Carney","sequence":"additional","affiliation":[{"name":"16University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Thompson","sequence":"additional","affiliation":[{"name":"17Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Gayther","sequence":"additional","affiliation":[{"name":"18Gynaecolgical Cancer Research Centre, University College London, EGA Institute for Women's Health, London, United Kingdom;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Ramus","sequence":"additional","affiliation":[{"name":"18Gynaecolgical Cancer Research Centre, University College London, EGA Institute for Women's Health, London, United Kingdom;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Jacobs","sequence":"additional","affiliation":[{"name":"18Gynaecolgical Cancer Research Centre, University College London, EGA Institute for Women's Health, London, United Kingdom;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kru\u0308ger Kjaer","sequence":"additional","affiliation":[{"name":"19Department of Virus, Hormones and Cancer, Copenhagen, Danish Cancer Society and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estrid","family":"Hogdall","sequence":"additional","affiliation":[{"name":"19Department of Virus, Hormones and Cancer, Copenhagen, Danish Cancer Society and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Blaakaer","sequence":"additional","affiliation":[{"name":"21Department of Gynecology and Obstetrics, Aarhus University Hospital, Skejby, Aarhus, Denmark;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Hogdall","sequence":"additional","affiliation":[{"name":"20The Gynaecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[{"name":"21Department of Gynecology and Obstetrics, Aarhus University Hospital, Skejby, Aarhus, Denmark;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Song","sequence":"additional","affiliation":[{"name":"23Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.P.","family":"Pharoah","sequence":"additional","affiliation":[{"name":"23Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Whittemore","sequence":"additional","affiliation":[{"name":"24Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"McGuire","sequence":"additional","affiliation":[{"name":"24Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Quaye","sequence":"additional","affiliation":[{"name":"18Gynaecolgical Cancer Research Centre, University College London, EGA Institute for Women's Health, London, United Kingdom;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[{"name":"24Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Ziogas","sequence":"additional","affiliation":[{"name":"24Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[{"name":"25Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Cramer","sequence":"additional","affiliation":[{"name":"26Obstetrics and Gynecology Epidemiology Center and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[{"name":"27Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[{"name":"27Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Calingaert","sequence":"additional","affiliation":[{"name":"1Comprehensive Cancer Center, Departments of"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chanock","sequence":"additional","affiliation":[{"name":"9Core Genotyping Facility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland;"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sherman","sequence":"additional","affiliation":[{"name":"8Division of Cancer Epidemiology and Genetics, National Cancer Institute and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garcia-Closas","sequence":"additional","affiliation":[{"name":"8Division of Cancer Epidemiology and Genetics, National Cancer Institute and"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"},{"name":"28The Ovarian Cancer Association Consortium, Durham, North Carolina"},{"name":"22Cancer Research UK Genetic Epidemiology Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Australian Cancer Study (Ovarian Cancer)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Australian Ovarian Cancer Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,3,17]]},"reference":[{"key":"2022061701474461600_B1","doi-asserted-by":"crossref","unstructured":"Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science\u20081990; 250: 1233\u20138.","DOI":"10.1126\/science.1978757"},{"key":"2022061701474461600_B2","doi-asserted-by":"crossref","unstructured":"Kmet L, Cook L, Magliocco A. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer\u20082003; 97: 389\u2013404.","DOI":"10.1002\/cncr.11064"},{"key":"2022061701474461600_B3","doi-asserted-by":"crossref","unstructured":"Berchuck A, Kohler MF, Hopkins MP, et al. Overexpression of p53 is not a feature of benign and early stage borderline epithelial ovarian tumors. Gynecol Oncol\u20081994; 52: 232\u20136.","DOI":"10.1006\/gyno.1994.1037"},{"key":"2022061701474461600_B4","doi-asserted-by":"crossref","unstructured":"Havrilesky L, Darcy M, Hamdan H, et al. Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol\u20082003; 21: 3814\u201325.","DOI":"10.1200\/JCO.2003.11.052"},{"key":"2022061701474461600_B5","doi-asserted-by":"crossref","unstructured":"Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol\u20082001; 13: 332\u20137.","DOI":"10.1016\/S0955-0674(00)00216-7"},{"key":"2022061701474461600_B6","doi-asserted-by":"crossref","unstructured":"Beenken SW, Karsenty G, Raycroft L, Lozano G. An intron binding protein is required for transformation ability of p53. Nucleic Acids Res\u20081991; 19: 4747\u201352.","DOI":"10.1093\/nar\/19.17.4747"},{"key":"2022061701474461600_B7","doi-asserted-by":"crossref","unstructured":"Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol\u20081987; 7: 961\u20133.","DOI":"10.1128\/MCB.7.2.961"},{"key":"2022061701474461600_B8","doi-asserted-by":"crossref","unstructured":"Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol\u20081999; 19: 1092\u2013100.","DOI":"10.1128\/MCB.19.2.1092"},{"key":"2022061701474461600_B9","doi-asserted-by":"crossref","unstructured":"Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A\u20081996; 93: 15335\u201340.","DOI":"10.1073\/pnas.93.26.15335"},{"key":"2022061701474461600_B10","doi-asserted-by":"crossref","unstructured":"Singer G, Stohr R, Cope L, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol\u20082005; 29: 218\u201324.","DOI":"10.1097\/01.pas.0000146025.91953.8d"},{"key":"2022061701474461600_B11","unstructured":"Hogdall E, Kjaer S, Glud E, et al. Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish \u201cMalova\u201d Ovarian Cancer Study. Anticancer Res\u20082003; 23: 3397\u2013404."},{"key":"2022061701474461600_B12","doi-asserted-by":"crossref","unstructured":"Campbell IG, Eccles DM, Dunn B, Davis M, Leake V. P53 polymorphism in ovarian and breast cancer. Lancet\u20081996; 347: 393\u20134.","DOI":"10.1016\/S0140-6736(96)90569-3"},{"key":"2022061701474461600_B13","doi-asserted-by":"crossref","unstructured":"Lancaster JM, Brownlee HA, Wiseman R, Taylor J. P53 polymorphism in ovarian and bladder cancer. Lancet\u20081995; 346: 182.","DOI":"10.1016\/S0140-6736(95)91239-8"},{"key":"2022061701474461600_B14","doi-asserted-by":"crossref","unstructured":"Peller S, Halperin R, Schneider D, Kopilova Y, Rotter V. Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma. Oncol Rep\u20081999; 6: 193\u20137.","DOI":"10.3892\/or.6.1.193"},{"key":"2022061701474461600_B15","doi-asserted-by":"crossref","unstructured":"Wang-Gohrke S, Weikel W, Risch H, et al. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer\u20081999; 81: 179\u201383.","DOI":"10.1038\/sj.bjc.6690669"},{"key":"2022061701474461600_B16","doi-asserted-by":"crossref","unstructured":"Agorastos T, Masouridou S, Lambropoulos AF, et al. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur J Cancer Prev\u20082004; 13: 277\u201380.","DOI":"10.1097\/01.cej.0000136717.95465.09"},{"key":"2022061701474461600_B17","unstructured":"Hogdall E, Hogdall C, Christensen L, et al. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients and their prognostic significance in ovarian cancer patients. Anticancer Res\u20082002; 22: 1859\u201364."},{"key":"2022061701474461600_B18","doi-asserted-by":"crossref","unstructured":"Pegoraro RJ, Moodley M, Rom L, Chetty R, Moodley J. P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans. Int J Gynecol Cancer\u20082003; 13: 444\u20139.","DOI":"10.1136\/ijgc-00009577-200307000-00007"},{"key":"2022061701474461600_B19","doi-asserted-by":"crossref","unstructured":"Ueda M, Terai Y, Kanda K, et al. Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol\u20082006; 100: 173\u20138.","DOI":"10.1016\/j.ygyno.2005.08.015"},{"key":"2022061701474461600_B20","doi-asserted-by":"crossref","unstructured":"Mavridou D, Gornall R, Campbell IG, Eccles DM. TP53 intron 6 polymorphism and the risk of ovarian and breast cancer. Br J Cancer\u20081998; 77: 676\u20137.","DOI":"10.1038\/bjc.1998.108"},{"key":"2022061701474461600_B21","doi-asserted-by":"crossref","unstructured":"Schildkraut J, Moorman P, Bland A, et al. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Cancer Epidemiol Biomarkers Prev\u20082008; 17: 1\u20139.","DOI":"10.1158\/1055-9965.EPI-07-0596"},{"key":"2022061701474461600_B22","doi-asserted-by":"crossref","unstructured":"Sellers T, Huang Y, Cunningham J, et al. Association of SNPs in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev\u20082008; 17: 397\u2013404.","DOI":"10.1158\/1055-9965.EPI-07-0565"},{"key":"2022061701474461600_B23","unstructured":"Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility Loci by clinical and pathological characteristics. PLoS Genet\u20082008; 4: e1000054."},{"key":"2022061701474461600_B24","doi-asserted-by":"crossref","unstructured":"The International HapMap Project. Nature\u20082003; 426: 789\u201396.","DOI":"10.1038\/nature02168"},{"key":"2022061701474461600_B25","doi-asserted-by":"crossref","unstructured":"Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet\u20082004; 74: 106\u201320.","DOI":"10.1086\/381000"},{"key":"2022061701474461600_B26","doi-asserted-by":"crossref","unstructured":"Merritt M, Green A, Nagle C, Webb P. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer\u20082008; 122: 170\u20136.","DOI":"10.1002\/ijc.23017"},{"key":"2022061701474461600_B27","doi-asserted-by":"crossref","unstructured":"McGuire V, Felberg A, Mills M, et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol\u20082004; 160: 613\u20138.","DOI":"10.1093\/aje\/kwh284"},{"key":"2022061701474461600_B28","doi-asserted-by":"crossref","unstructured":"Bushley A, Ferrell R, McDuffie K, et al. Polymorphisms of interleukin (IL)-1\u03b1, IL-1\u03b2, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol\u20082004; 95: 672\u20139.","DOI":"10.1016\/j.ygyno.2004.08.024"},{"key":"2022061701474461600_B29","doi-asserted-by":"crossref","unstructured":"Soegaard M, Jensen A, Hogdall E, et al. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev\u20082007; 16: 1160\u20136.","DOI":"10.1158\/1055-9965.EPI-07-0089"},{"key":"2022061701474461600_B30","doi-asserted-by":"crossref","unstructured":"Terry K, De Vivo I, Titus-Ernstoff L, Shih M-C, Cramer D. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res\u20082005; 65: 5974\u201381.","DOI":"10.1158\/0008-5472.CAN-04-3885"},{"key":"2022061701474461600_B31","doi-asserted-by":"crossref","unstructured":"Gates M, Tworoger S, Hecht J, De Vivo I, Rosner B, Hankinson S. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer\u20082007; 121: 2225\u201332.","DOI":"10.1002\/ijc.22790"},{"key":"2022061701474461600_B32","doi-asserted-by":"crossref","unstructured":"Song H, Ramus SJ, Quaye L, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis\u20082006; 27: 2235\u201342.","DOI":"10.1093\/carcin\/bgl089"},{"key":"2022061701474461600_B33","doi-asserted-by":"crossref","unstructured":"Pike M, Pearch C, Peters R, Cozen W, Wan P, Wu A. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril\u20082004; 82: 186\u201395.","DOI":"10.1016\/j.fertnstert.2004.03.013"},{"key":"2022061701474461600_B34","unstructured":"Ziogas A, Gildea M, Cohen P, et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev\u20082000; 9: 103\u201311."},{"key":"2022061701474461600_B35","doi-asserted-by":"crossref","unstructured":"Ramus SJ, Vierkant RA, Johnatty SE, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer\u20082008; 123: 380\u20138.","DOI":"10.1002\/ijc.23448"},{"key":"2022061701474461600_B36","doi-asserted-by":"crossref","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics\u20082005; 21: 263\u20135.","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"2022061701474461600_B37","doi-asserted-by":"crossref","unstructured":"Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. StatComp\u20082000; 10: 325\u201337.","DOI":"10.1023\/A:1008929526011"},{"key":"2022061701474461600_B38","unstructured":"Jeffreys H. Theory of Probability. 3rd ed. Oxford (UK): Oxford University Press; 1961."},{"key":"2022061701474461600_B39","doi-asserted-by":"crossref","unstructured":"Kass RE, Raftery AE. Bayes Factors. J Am Stat Assoc\u20081995; 90: 773\u201395.","DOI":"10.1080\/01621459.1995.10476572"},{"key":"2022061701474461600_B40","doi-asserted-by":"crossref","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials\u20081986; 7: 177\u201388.","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2022061701474461600_B41","unstructured":"Buller RE, Sood A, Fullenkamp C, Sorosky J, Powills K, Anderson B. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther\u20081997; 4: 239\u201345."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/6\/2349\/2623616\/2349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/6\/2349\/2623616\/2349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:52:40Z","timestamp":1655441560000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/6\/2349\/553306\/Single-Nucleotide-Polymorphisms-in-the-TP53-Region"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,15]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,3,17]]},"published-print":{"date-parts":[[2009,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-2902","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499655.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499655","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22380737","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380725","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380734","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380740.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380722","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380734.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380737.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380731.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380731","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380740","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380722.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380725.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,15]]}}}